Heterogeneity in the pharmacological management of radiation-induced hemorrhagic cystitis
- 10 October 2022
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 40 (12) , 540.e11-540.e17
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A Practical Approach to the Management of Radiation-Induced Hemorrhagic CystitisDrugs, 2015
- Management of radiation cystitisNature Reviews Urology, 2010
- USP releases revision of chapter on sterile compoundingAmerican Journal of Health-System Pharmacy, 2008
- Impact ofUnited States Pharmacopeiachapter 797: Results of a national surveyAmerican Journal of Health-System Pharmacy, 2006
- The management of haemorrhagic cystitis with sodium pentosan polysulphateBJU International, 2004
- Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis2002
- Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelinesBMJ, 1999
- Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluationsThe Lancet, 1993
- Containing Costs While Improving Quality of Care: The Role of Profiling and Practice GuidelinesAnnual Review of Public Health, 1993
- Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhageUrology, 1992